BioLumic Raises $13.5 Million in Series B Financing NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- BioLumic Inc. (“BioLumic”) today announced the closing of a $13.5-million Series B funding round that will be used to accelerate commercial growth for its...

BioLumic announces Scientific Advisory Group NEW YORK and PALMERSTON NORTH, New Zealand, Aug. 16, 2021 (GLOBE NEWSWIRE) -- BioLumic Inc. (“BioLumic”), a biotechnology company that develops photomorphogenic light signals for agriculture, today...